What are the most common retatrutide side effects?

The most common side effects are gastrointestinal: nausea (40-50%), decreased appetite (50-60%), diarrhea (20-30%), and vomiting (15-25%). These typically occur during dose escalation and improve after 2-4 weeks at each dose level.

Are retatrutide side effects worse than Semaglutide?

Side effect rates in retatrutide trials are similar to other GLP-1 agonists. The glucagon component may cause slightly different patterns, but overall tolerability appears comparable. Most side effects are dose-dependent and manageable with slow titration.

How long do retatrutide side effects last?

Most GI side effects peak during the first 2-4 weeks at each new dose level, then gradually improve. By 8-12 weeks of stable dosing, most people have minimal side effects. Persistent severe symptoms should be reported to your healthcare provider.

Can I take anti-nausea medication with retatrutide?

Yes, ondansetron (Zofran) or other antiemetics can be used to manage nausea during dose titration. Ginger supplements and eating small, frequent meals can also help. Discuss medication options with your healthcare provider.

Who should not take retatrutide?

Retatrutide should be avoided by those with: personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN2), severe gastrointestinal disease, or hypersensitivity to any GLP-1 agonists. Pregnant or breastfeeding women should not use retatrutide.

Does retatrutide cause muscle loss?

Like all weight loss interventions, some lean mass loss occurs alongside fat loss. Clinical trials show retatrutide produces favorable body composition changes with significant fat mass reduction. Resistance training and adequate protein intake (1.2-1.6g/kg) help preserve muscle.

PeptideKey Research Library

GLP-1 Retatrutide: 350% GH Boost, 25% Fat Loss? 54 Studies

Investigate potential Retatrutide side effects in research. This guide details reported reactions, safety protocols, and how to mitigate risks for responsible study. Evidence-based.

This research guide is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.